Envestnet Asset Management’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-9,491
| Closed | -$758K | – | 3740 |
|
|
2021
Q1 | $758K | Sell |
9,491
-7,287
| -43% | -$569K | ﹤0.01% | 2598 |
|
|
2020
Q4 | $1.32M | Buy |
16,778
+1,790
| +12% | +$105K | ﹤0.01% | 2019 |
|
|
2020
Q3 | $659K | Sell |
14,988
-6,486
| -30% | -$320K | ﹤0.01% | 2324 |
|
|
2020
Q2 | $950K | Sell |
21,474
-45,797
| -68% | -$1.71M | ﹤0.01% | 2001 |
|
|
2020
Q1 | $2.42M | Buy |
67,271
+7,431
| +12% | +$423K | ﹤0.01% | 1333 |
|
|
2019
Q4 | $4.24M | Buy |
59,840
+3,665
| +7% | +$266K | ﹤0.01% | 1220 |
|
|
2019
Q3 | $4.2M | Buy |
56,175
+8,655
| +18% | +$734K | ﹤0.01% | 1152 |
|
|
2019
Q2 | $3.83M | Buy |
47,520
+6,984
| +17% | +$491K | ﹤0.01% | 1201 |
|
|
2019
Q1 | $2.71M | Sell |
40,536
-336
| -0.8% | -$25.4K | ﹤0.01% | 1321 |
|
|
2018
Q4 | $3.04M | Buy |
+40,872
| New | +$3.37M | ﹤0.01% | 1124 |
|
|
2018
Q3 | – | Sell |
-5,079
| Closed | -$499K | – | 2893 |
|
|
2018
Q2 | $499K | Buy |
5,079
+426
| +9% | +$47.6K | ﹤0.01% | 1324 |
|
|
2018
Q1 | $519K | Sell |
4,653
-221
| -5% | -$24.8K | ﹤0.01% | 1196 |
|
|
2017
Q4 | $501K | Sell |
4,874
-314
| -6% | -$31.3K | ﹤0.01% | 1492 |
|
|
2017
Q3 | $488K | Sell |
5,188
-528
| -9% | -$41.7K | ﹤0.01% | 1484 |
|
|
2017
Q2 | $445K | Buy |
5,716
+13
| +0.2% | +$976 | ﹤0.01% | 1544 |
|
|
2017
Q1 | $456K | Buy |
5,703
+294
| +5% | +$23.4K | ﹤0.01% | 1570 |
|
|
2016
Q4 | $424K | Buy |
5,409
+42
| +0.8% | +$3.26K | ﹤0.01% | 1580 |
|
|
2016
Q3 | $419K | Sell |
5,367
-1,000
| -16% | -$72.5K | ﹤0.01% | 1668 |
|
|
2016
Q2 | $438K | Sell |
6,367
-1,633
| -20% | -$113K | ﹤0.01% | 1713 |
|
|
2016
Q1 | $571K | Sell |
8,000
-244
| -3% | -$15.3K | ﹤0.01% | 1581 |
|
|
2015
Q4 | $512K | Sell |
8,244
-40
| -0.5% | -$2.44K | ﹤0.01% | 1578 |
|
|
2015
Q3 | $470K | Buy |
8,284
+512
| +7% | +$27.1K | ﹤0.01% | 1630 |
|
|
2015
Q2 | $417K | Sell |
7,772
-1,994
| -20% | -$97K | ﹤0.01% | 1805 |
|
|
2015
Q1 | $464K | Buy |
9,766
+8,687
| +805% | +$385K | ﹤0.01% | 1587 |
|
|
2014
Q4 | $47K | Sell |
1,079
-481
| -31% | -$19.7K | ﹤0.01% | 1440 |
|
|
2014
Q3 | $54K | Sell |
1,560
-130
| -8% | -$4.59K | ﹤0.01% | 1498 |
|
|
2014
Q2 | $62K | Buy |
1,690
+157
| +10% | +$5.33K | ﹤0.01% | 1370 |
|
|
2014
Q1 | $52K | Buy |
1,533
+53
| +4% | +$1.75K | ﹤0.01% | 1353 |
|
|
2013
Q4 | $50K | Buy |
1,480
+266
| +22% | +$9.21K | ﹤0.01% | 1216 |
|
|
2013
Q3 | $39K | Sell |
1,214
-436
| -26% | -$11.6K | ﹤0.01% | 1270 |
|
|
2013
Q2 | $37K | Buy |
+1,650
| New | +$35.7K | ﹤0.01% | 1253 |
|
Envestnet Asset Management's CMD Position: Q2 2021 in Review
Envestnet Asset Management sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 9,491 shares — an estimated $758K sold.
Envestnet Asset Management first reported a position in CMD in Q2 2013 and held it in 31 quarters. The position peaked at $4.24M in Q4 2019. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Envestnet Asset Management reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Envestnet Asset Management sold 9,491 Cantel Medical Corporation shares in Q2 2021, an estimated $758K.
- Envestnet Asset Management first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 31 quarters.
- Envestnet Asset Management's Cantel Medical Corporation position peaked at $4.24M in Q4 2019.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Envestnet Asset Management's 13F filing for Q2 2021, filed 4 Aug 2021.